HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Nozomi Niitsu Selected Research
Nozomi Niitsu Research Topics
Disease
10
B-Cell Lymphoma (Lymphoma, B Cell)
01/2020 - 08/2002
10
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
02/2015 - 09/2006
10
Lymphoma (Lymphomas)
03/2014 - 02/2002
8
Neoplasms (Cancer)
02/2015 - 08/2002
5
Non-Hodgkin Lymphoma (Lymphosarcoma)
09/2010 - 02/2002
4
Leukemia
01/2018 - 11/2002
3
Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2005 - 11/2002
2
Hodgkin Disease (Hodgkin's Disease)
11/2011 - 09/2006
2
Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
06/2011 - 01/2007
2
Acute Promyelocytic Leukemia
07/2010 - 11/2002
2
Cardiotoxicity
01/2005 - 11/2002
2
Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
11/2003 - 02/2002
1
Neoplasm Metastasis (Metastasis)
01/2018
1
Breast Neoplasms (Breast Cancer)
01/2018
1
Pericardial Effusion
12/2014
1
T-Cell Lymphoma (Lymphoma, T Cell)
05/2011
1
Infections
12/2010
1
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
07/2010
1
Lymphoproliferative Disorders (Lymphoproliferative Disorder)
05/2010
1
Rheumatoid Arthritis
05/2010
1
Marfan Syndrome (Marfan's Syndrome)
03/2010
1
Plasmablastic Lymphoma
01/2010
1
Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
06/2009
1
Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
01/2008
1
Cardiomyopathies (Cardiomyopathy)
01/2005
1
Pancytopenia
11/2004
1
Paralysis (Palsy)
11/2003
1
Myeloid Leukemia (Leukemia, Myelocytic)
11/2002
1
Carcinogenesis
11/2002
Drug/Important Bio-Agent (IBA)
13
Rituximab (Mabthera)
FDA Link
01/2020 - 06/2004
5
Cyclophosphamide (Cytoxan)
FDA Link
Generic
01/2020 - 06/2004
5
Doxorubicin (Adriamycin)
FDA Link
Generic
01/2020 - 06/2004
5
Vincristine (Oncovin)
FDA Link
Generic
01/2020 - 06/2004
4
Prednisolone (Predate)
FDA Link
Generic
01/2020 - 11/2003
4
Tretinoin (Retinoic Acid)
FDA Link
Generic
01/2018 - 08/2002
4
Proteins (Proteins, Gene)
FDA Link
01/2014 - 04/2003
3
Methotrexate (Mexate)
FDA Link
Generic
01/2020 - 11/2003
3
Monoclonal Antibodies
IBA
03/2014 - 06/2004
3
Dexamethasone (Maxidex)
FDA Link
Generic
01/2007 - 11/2003
3
Etoposide (VP 16)
FDA Link
Generic
09/2006 - 01/2005
3
Prednisone (Sone)
FDA Link
Generic
06/2006 - 06/2004
2
Bendamustine Hydrochloride
FDA Link
02/2015 - 06/2013
2
Granzymes (Granzyme)
IBA
02/2010 - 11/2003
2
Irinotecan (Camptosar)
FDA Link
Generic
01/2007 - 09/2006
2
Mitoxantrone (Novantrone)
FDA Link
Generic
01/2007 - 09/2006
2
Bleomycin (Blenoxane)
FDA Link
Generic
09/2006 - 06/2006
2
Granulocyte Colony-Stimulating Factor (G-CSF)
IBA
01/2005 - 06/2004
1
lysophosphatidic acid
IBA
01/2018
1
Lysophosphatidic Acid Receptors
IBA
01/2018
1
Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)
FDA Link
02/2015
1
Proteasome Inhibitors
IBA
03/2014
1
Histones (Histone)
IBA
03/2014
1
B-Cell Antigen Receptors (B Cell Antigen Receptors)
IBA
01/2013
1
fascin
IBA
11/2011
1
Biomarkers (Surrogate Marker)
IBA
06/2011
1
L-Lactate Dehydrogenase (Lactate Dehydrogenase)
IBA
05/2011
1
Hepatitis B Surface Antigens (HBsAg)
FDA Link
12/2010
1
Ellagic Acid
IBA
07/2010
1
Pharmaceutical Preparations
IBA
07/2010
1
Antioxidants
IBA
07/2010
1
Transforming Growth Factor beta Receptors (TGF beta Receptors)
IBA
03/2010
1
Transforming Growth Factor beta (TGF-beta)
IBA
03/2010
1
Fibrillins
IBA
03/2010
1
Dacarbazine (DIC)
FDA Link
Generic
06/2009
1
Pyridinolcarbamate (P23)
IBA
06/2009
1
growth arrest specific transcript 5
IBA
04/2008
1
Procarbazine (Matulane)
FDA Link
09/2006
1
Melphalan (Alkeran)
FDA Link
Generic
11/2005
1
Immunoglobulin G (IgG)
IBA
11/2005
1
Brain Natriuretic Peptide (Natrecor)
FDA Link
01/2005
1
Troponin T (Troponin T1)
IBA
01/2005
1
Progesterone
FDA Link
Generic
11/2004
1
theasinensin A
IBA
05/2004
1
Interleukin-2 Receptors (IL 2 Receptor)
IBA
04/2004
1
C-Reactive Protein
IBA
04/2004
1
Biological Products
IBA
04/2003
1
1,2-bis(3,5-dioxopiperazin-1-yl)ethane
IBA
11/2002
1
Catalytic DNA (Deoxyribozyme)
IBA
11/2002
1
Topoisomerase II Inhibitors
IBA
11/2002
1
4,4'- (1,2- dimethyl- 1,2- ethanediyl)bis- 2,6- piperazinedione
IBA
11/2002
1
6-sulfo sialyl Lewis X
IBA
08/2002
1
Interferon-gamma (Interferon, gamma)
IBA
08/2002
1
Immunosorbents
IBA
03/2002
1
Enzymes
IBA
03/2002
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
02/2002
1
Interleukin-6 (Interleukin 6)
IBA
02/2002
Therapy/Procedure
9
Drug Therapy (Chemotherapy)
01/2020 - 11/2002
7
Therapeutics
06/2013 - 08/2002
5
Radiotherapy
12/2014 - 11/2002
2
PACEBO protocol
06/2011 - 12/2006
2
VAP-cyclo protocol
06/2010 - 06/2004
1
Stem Cell Transplantation
06/2013
1
Combination Drug Therapy (Combination Chemotherapy)
12/2010
1
Splenectomy
01/2009
1
Salvage Therapy
01/2005
1
Cesarean Section (Caesarean Section)
11/2004
1
Hysterectomy
11/2002
1
Salpingo-oophorectomy
11/2002